Tom Woiwode has worked at Versant since 2002 in operational and investment roles, becoming Managing Director in 2014. He previously was a medicinal chemist at XenoPort and holds a Ph.D. in chemistry from Stanford.
At firms with a similar stage, sector and check size.




One email when Tom's firm raises a fund, adds a partner or shows new activity.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckTom Woiwode has worked at Versant since 2002 in operational and investment roles, becoming Managing Director in 2014. He previously was a medicinal chemist at XenoPort and holds a Ph.D. in chemistry from Stanford.
Versant Ventures has not reported a check size. It invests at seed, series a, series b.
A warm intro from a founder Versant Ventures backed works best. A short LinkedIn note with one line on traction is the next best route.
medicinal chemist at XenoPort; CBO at Amira; CBO at Synosia; CBO at Flexion; COO at Okairos.
Last updated 2026-10-15. Is this you? Ask for a correction.